S10E7: A conversation with Recordati's Dr. Mario Maldonado
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
S10E7: A conversation with Recordati's Dr. Mario Maldonado
-
Narrated by:
-
By:
About this listen
Today's podcast features my chat with Dr. Mario Maldonado, Head of Development and Global Endocrinology atRecordati Rare Diseases. Dr. Maldonado brings a wealth of experience and a great perspective on drug development. He was involved in developing both pasireotide and osilodrostat, two essential compounds used in drugs to treat Cushing's. Listen to this fascinating talk with one of the most dynamic experts in endocrine drug development today. He talks about endocrinology, the science of cortisol production, the art and science of endocrine medicine, and the opportunities for new drugs and therapies in the US and Europe. We also focused on the findings from a Recordati new study, LINC-7, - read more about the study here - potentially leading to new indications (uses) for osilodrostat (Isturisa®).
Click here for more information and content on Cushing's and hypercortisolism from Pituitary World News.
Now available, Dr. Lewis Blevins new book "Cushing's; a comprehensive guide to understanding a devastating disease". Click here to buy your copy today or click on the book graphic below.